The pure research funded by taxpayers via the NIH or university research represents a tiny fraction of the cost of getting a new treatment to market. The paten

The pure research funded by taxpayers via the NIH or university research represents a tiny fraction of the cost of getting a new treatment to market. The patents cover the risk of taking raw research through testing and development stages that can cost hundreds of millions of dollars and still not deliver a viable product at the end of the process.